Analytical Chemistry,
Год журнала:
2023,
Номер
95(9), С. 4486 - 4495
Опубликована: Фев. 20, 2023
Exosomal
microRNAs
(exomiRNAs)
have
emerged
as
ideal
biomarkers
for
early
clinical
diagnostics.
The
accurate
detection
of
exomiRNAs
plays
a
crucial
role
in
facilitating
applications.
Herein,
an
ultrasensitive
electrochemiluminescent
(ECL)
biosensor
was
constructed
using
three-dimensional
(3D)
walking
nanomotor-mediated
CRISPR/Cas12a
and
tetrahedral
DNA
nanostructures
(TDNs)-modified
nanoemitters
(TCPP-Fe@HMUiO@Au-ABEI)
exomiR-155
detection.
Initially,
the
3D
strategy
could
effectively
convert
target
into
amplified
biological
signals
improving
sensitivity
specificity.
Then,
TCPP-Fe@HMUiO@Au
nanozymes
with
excellent
catalytic
performance
were
used
to
amplify
ECL
because
enhanced
mass
transfer
increased
active
sites,
originating
from
its
high
surface
areas
(601.83
m2/g),
average
pore
size
(3.46
nm),
large
volumes
(0.52
cm3/g).
Meanwhile,
TDNs
scaffold
fabricate
"bottom-up"
anchor
bioprobes
improve
trans-cleavage
efficiency
Cas12a.
Consequently,
this
achieved
limit
down
273.20
aM
ranging
1.0
fM
nM.
Furthermore,
discriminate
breast
cancer
patients
evidently
by
analyzing
exomiR-155,
these
results
conformed
that
qRT-PCR.
Thus,
work
provides
promising
tool
Signal Transduction and Targeted Therapy,
Год журнала:
2023,
Номер
8(1)
Опубликована: Сен. 21, 2023
Abstract
Ferroptosis
is
an
iron-dependent
form
of
regulated
cell
death
with
distinct
characteristics,
including
altered
iron
homeostasis,
reduced
defense
against
oxidative
stress,
and
abnormal
lipid
peroxidation.
Recent
studies
have
provided
compelling
evidence
supporting
the
notion
that
ferroptosis
plays
a
key
pathogenic
role
in
many
diseases
such
as
various
cancer
types,
neurodegenerative
disease,
involving
tissue
and/or
organ
injury,
inflammatory
infectious
diseases.
Although
precise
regulatory
networks
underlie
are
largely
unknown,
particularly
respect
to
initiation
progression
diseases,
recognized
bona
fide
target
for
further
development
treatment
prevention
strategies.
Over
past
decade,
considerable
progress
has
been
made
developing
pharmacological
agonists
antagonists
these
ferroptosis-related
conditions.
Here,
we
provide
detailed
overview
our
current
knowledge
regarding
ferroptosis,
its
pathological
roles,
regulation
during
disease
progression.
Focusing
on
use
chemical
tools
preclinical
studies,
also
summarize
recent
advances
targeting
across
growing
spectrum
ferroptosis-associated
Finally,
discuss
new
challenges
opportunities
potential
strategy
treating
Frontiers in Pharmacology,
Год журнала:
2022,
Номер
13
Опубликована: Авг. 29, 2022
The
activation
of
ferroptosis
is
a
new
effective
way
to
treat
drug-resistant
solid
tumors.
Ferroptosis
an
iron-mediated
form
cell
death
caused
by
the
accumulation
lipid
peroxides.
intracellular
imbalance
between
oxidant
and
antioxidant
due
abnormal
expression
multiple
redox
active
enzymes
will
promote
produce
reactive
oxygen
species
(ROS).
So
far,
few
pathways
regulators
have
been
discovered
regulate
ferroptosis.
In
particular,
cystine/glutamate
antiporter
(System
X
c
−
),
glutathione
peroxidase
4
(GPX4)
(GSH)
/GSH/GPX4
axis)
plays
key
role
in
preventing
peroxidation-mediated
ferroptosis,
because
which
could
be
inhibited
blocking
System
axis.
This
review
aims
present
current
understanding
mechanism
based
on
axis
treatment
Trends in Molecular Medicine,
Год журнала:
2023,
Номер
29(9), С. 753 - 764
Опубликована: Июнь 24, 2023
Ferroptosis
suppressor
protein
1
(FSP1)
is
one
of
the
main
regulatory
molecules
ferroptosis.
FSP1
functions
through
FSP1-coenzyme
Q10
(CoQ10)-NAD(P)H
axis
and
vitamin
K
redox
cycle.
regulated
by
upstream
factors,
including
transcription
factors
noncoding
RNA
(ncRNA),
subject
to
epigenetic
modifications,
which
affect
progress
FSP1-related
diseases.
closely
associated
with
poor
prognosis
malignant
tumors
plays
an
important
role
in
disease
treatment.
This
review
aims
provide
a
comprehensive
understanding
ferroptosis
regulation
summarizing
pathways,
possible
mechanisms
involving
FSP1,
relationship
between
Bioactive Materials,
Год журнала:
2022,
Номер
22, С. 141 - 167
Опубликована: Сен. 29, 2022
Currently,
there
are
no
clinical
drugs
available
to
treat
acute
kidney
injury
(AKI).
Given
the
high
prevalence
and
mortality
rate
of
AKI,
development
effectively
AKI
is
a
huge
unmet
medical
need
research
hotspot.
Although
existing
evidence
fully
demonstrates
that
reactive
oxygen
nitrogen
species
(RONS)
burst
at
site
major
contributor
progression,
heterogeneity,
complexity,
unique
physiological
structure
make
most
antioxidant
anti-inflammatory
small
molecule
ineffective
because
lack
targeting
side
effects.
Recently,
nanodrugs
with
intrinsic
through
control
size,
shape,
surface
properties
have
opened
exciting
prospects
for
treatment
AKI.
Many
emerged
address
limitations
current
treatments.
In
this
review,
we
systematically
summarized
first
time
about
emerging
exploit
pathological
features
overcome
traditional
small-molecule
achieve
efficacy.
First,
analyzed
structural
characteristics
main
mechanism
AKI:
hypoxia,
harmful
substance
accumulation-induced
RONS
renal
despite
multifactorial
initiation
heterogeneity
Subsequently,
introduced
strategies
used
improve
reviewed
advances
nano-RONS-sacrificial
agents,
nanozymes,
nanocarriers
antioxidants
drugs.
These
demonstrated
excellent
therapeutic
effects,
such
as
greatly
reducing
oxidative
stress
damage,
restoring
function,
low
Finally,
discussed
challenges
future
directions
translating
into
treatment.
ACS Nano,
Год журнала:
2023,
Номер
17(5), С. 4667 - 4687
Опубликована: Март 2, 2023
The
hypoxia
microenvironment
of
solid
tumors
poses
a
technological
bottleneck
for
ferroptosis
and
immunotherapy
in
clinical
oncology.
Nanoreactors
based
on
special
physiological
signals
tumor
cells
are
able
to
avoid
various
tolerance
mechanisms
by
alleviating
the
intracellular
environment.
Herein
we
reported
nanoreactor
Cu2-xSe
that
enabled
conversion
Cu
elements
between
Cu+
Cu2+
generation
O2
consumption
GSH
content.
Furthermore,
enhance
catalytic
ferroptosis-inducing
activities
nanoreactors,
agonist
Erastin
was
loaded
ZIF-8
coating
surface
up-regulate
expression
NOX4
protein,
increase
H2O2
content,
catalyze
produce
activate
ferroptosis.
In
addition,
nanoreactors
were
simultaneously
functionalized
with
PEG
polymer
folic
acid
molecules,
which
ensured
vivo
blood
circulation
tumor-specific
uptake.
vitro
experiments
demonstrated
self-supplying
can
amplify
ability
generate
consume
via
interconversion
Cu2+,
impair
GPX4/GSH
pathway
HIF-1α
protein
expression.
At
same
time,
environment,
miR301,
gene
secreted
exosomes
decreased,
ultimately
affected
phenotype
polarization
TAMs
increased
content
IFN
γ
CD8+
T
cells,
further
promoted
induced
Erastin-loaded
nanoreactors.
This
combined
therapeutic
strategy
activating
immune
response
provides
potential
application.
ACS Nano,
Год журнала:
2023,
Номер
17(17), С. 16715 - 16730
Опубликована: Авг. 18, 2023
Photodynamic
therapy
(PDT)
still
faces
great
challenges
with
suitable
photosensitizers,
oxygen
supply,
and
reactive
species
(ROS)
accumulation,
especially
in
the
tumor
microenvironment,
feathering
hypoxia,
high
glucose
metabolism.
Herein,
a
carbon
dots
(CDs)-based
bifunctional
nanosystem
(MnZ@Au),
acting
as
photosensitizer
nanozyme
cascading
oxidase
(GOx)-
catalase
(CAT)-like
reactivity,
was
developed
for
improving
hypoxia
regulating
metabolism
to
enhance
PDT.
The
MnZ@Au
constructed
using
Mn-doped
CDs
(Mn-CDs)
core
zeolitic
imidazolate
framework-8
(ZIF-8)
shell
form
hybrid
(MnZ),
followed
by
anchoring
ultrasmall
Au
nanoparticles
(AuNPs)
onto
surface
of
MnZ
through
ion
exchange
situ
reduction
methods.
catalyzed
consumption
generation
GOx-
CAT-like
reactions,
which
further
enhanced
its
own
photothermal
properties.
In
vitro
vivo
studies
also
confirmed
that
greatly
improved
penetration,
promoted
ROS
PDT
efficacy,
leading
efficient
growth
inhibition
breast
model.
Besides,
enabled
photoacoustic
(PA)
imaging
provide
mapping
Mn-CDs
distribution
saturation,
showing
real-time
catalytic
process
vivo.
18F-Fluorodeoxyglucose
positron
emission
tomography
(18F-FDG
PET)
validated
decreased
uptake
tumors
treated
MnZ@Au.
Therefore,
integrated
design
provided
promising
strategy
utilize
regulate
promote
PDT,
finally
prevent
deterioration.
Journal of Hematology & Oncology,
Год журнала:
2024,
Номер
17(1)
Опубликована: Июнь 6, 2024
Abstract
Ferroptosis,
an
iron-dependent
form
of
cell
death
characterized
by
uncontrolled
lipid
peroxidation,
is
governed
molecular
networks
involving
diverse
molecules
and
organelles.
Since
its
recognition
as
a
non-apoptotic
pathway
in
2012,
ferroptosis
has
emerged
crucial
mechanism
numerous
physiological
pathological
contexts,
leading
to
significant
therapeutic
advancements
across
wide
range
diseases.
This
review
summarizes
the
fundamental
mechanisms
regulatory
pathways
underlying
ferroptosis,
including
both
GPX4-dependent
-independent
antioxidant
mechanisms.
Additionally,
we
examine
involvement
various
conditions,
cancer,
neurodegenerative
diseases,
sepsis,
ischemia–reperfusion
injury,
autoimmune
disorders,
metabolic
disorders.
Specifically,
explore
role
response
chemotherapy,
radiotherapy,
immunotherapy,
nanotherapy,
targeted
therapy.
Furthermore,
discuss
pharmacological
strategies
for
modulating
potential
biomarkers
monitoring
this
process.
Lastly,
elucidate
interplay
between
other
forms
regulated
death.
Such
insights
hold
promise
advancing
our
understanding
context
human
health
disease.
ACS Nano,
Год журнала:
2023,
Номер
18(1), С. 713 - 727
Опубликована: Дек. 20, 2023
Porphyrins
and
their
derivatives
are
widely
used
as
photosensitizers
sonosensitizers
in
tumor
treatment.
Nevertheless,
poor
water
solubility
low
chemical
stability
reduce
singlet
oxygen
(1O2)
yield
and,
consequently,
photodynamic
therapy
(PDT)
sonodynamic
(SDT)
efficiency.
Although
strategies
for
porphyrin
molecule
assembly
have
been
developed
to
augment
1O2
generation,
there
is
scope
further
improving
PDT
SDT
efficiencies.
Herein,
we
synthesized
ordered
manganese
(SM)
nanoparticles
with
well-defined
self-assembled
metalloporphyrin
networks
that
enabled
efficient
energy
transfer
enhanced
photocatalytic
sonocatalytic
activity
production.
Subsequently,
Au
were
grown
situ
on
the
SM
surface
by
anchoring
terminal
alkynyl
of
form
plasmonic
SMA
heterostructures,
which
showed
excellent
near-infrared-II
(NIR-II)
region
absorption
photothermal
properties,
facilitated
electron–hole
pair
separation
transfer.
With
modification
hyaluronic
acid
(HA),
SMAH
heterostructure
nanocomposites
exhibited
good
actively
targeted
cancer
cells.
Under
NIR-II
light
ultrasound
(US)
irradiation,
generates
hyperthermia,
a
large
amount
1O2,
inducing
cell
damage.
Both
vitro
vivo
studies
confirmed
effectively
suppressed
growth
decreasing
GSH
levels
SDT-augmented
PDT/PTT.
Moreover,
utilizing
strong
window,
can
achieve
photoacoustic
imaging-guided
combined
This
work
provides
paradigm
enhancing
metalloporphyrins
improve
synergistic
therapeutic
effect
SDT/PDT/PTT.